Use of castanospermine and substituted-castonospermine compounds for treating hepatitis virus infections

Compositions and methods are provided for treating hepatitis, flavivirus or pestivirus infections, especially hepatitis B or C virus infections, in mammals, especially humans.

Bibliographic Details
Main Authors:	Jacob, G, Jordan, R, Block, T, Zitzmann, N, Dwek, R
Format:	Patent
Published:	World Intellectual Property Organisation 2001

Similar Items

The structural basis of the inhibition of human glycosidases by castanospermine analogues.
by: Winchester, BG, et al.
Published: (1990)

Vinylogous Mukaiyama aldol reactions with 4-oxy-2-trimethylsilyloxypyrroles: relevance to castanospermine synthesis
by: Roger Hunter, et al.
Published: (2007-11-01)

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
by: Zitzmann, N, et al.
Published: (1999)

Protein-protein interactions: modeling the hepatitis C virus ion channel p7.
by: Patargias, G, et al.
Published: (2005)

Methods of treating Poxviral Infections
by: Ramstedt, U, et al.
Published: (2011)

Methods of treating orthomyxoviral infections
by: Ramstedt, U, et al.
Published: (2012)

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells.
by: Pollock, S, et al.
Published: (2010)

Iminosugars and methods of treating Arenaviral infections
by: Ramstedt, U, et al.
Published: (2010)

Retention of glucose by N-linked oligosaccharide chains impedes expression of lipoprotein lipase activity: effect of castanospermine.
by: H Masuno, et al.
Published: (1992-09-01)

The Hepatitis C Virus E2p7 localization and topology in a recombinant system
by: Popescu, C, et al.
Published: (2009)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
by: Narayan, R, et al.
Published: (2009)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
by: Steinmann, E, et al.
Published: (2007)

Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
by: Lazar, C, et al.
Published: (2007)

Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells.
by: Macovei, A, et al.
Published: (2010)

New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells.
by: Ghada Allan, et al.
Published: (2013-01-01)

Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
by: Mehta, A, et al.
Published: (2001)

Long chain n-alkyl compounds and oxa-derivatives thereof
by: Zitzmann, N, et al.
Published: (2016)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
by: Gangadharan, B, et al.
Published: (2012)

Long chain N-alkyl compounds and Oxa-derivatives thereof and use antiviral compositions
by: Zitzmann, N, et al.
Published: (2001)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
by: Gangadharan, B, et al.
Published: (2008)

N-alkyl deoxynojirimycins as antiviral compounds.
by: Moriarty, R, et al.
Published: (2002)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
by: Gangadharan, B, et al.
Published: (2010)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2007)

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
by: Chapel, C, et al.
Published: (2007)

Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein
by: Dorobantu, C, et al.
Published: (2011)

Glycobiology against viruses: Antiviral drug discovery
by: Zitzmann, N, et al.
Published: (2006)

Iminosugars and methods of treating Filoviral diseases
by: Ramstedt, U, et al.
Published: (2011)

Iminosugars and methods of treating viral diseases
by: Ramstedt, U, et al.
Published: (2011)

Combination therapy for treatment of viral infections
by: Jeffs, R, et al.
Published: (2009)

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2004)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
by: Ramstedt, U, et al.
Published: (2010)

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.
by: Pavlović, D, et al.
Published: (2003)

Alpha-glucosidase inhibitors as potential broad based anti-viral agents
by: Mehta, A, et al.
Published: (1998)

Management of hepatitis C virus (HCV) infection in drug substitution programs
by: K Hensel-Koch, et al.
Published: (2011-05-01)

The influence of different lipid environments on the structure and function of the hepatitis C virus p7 ion channel protein
by: Whitfield, T, et al.
Published: (2011)

Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
by: Chapel, C, et al.
Published: (2006)

The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy.
by: Luik, P, et al.
Published: (2009)

Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells.
by: Woodhouse, S, et al.
Published: (2008)

Use of iminosugar derivatives to inhibit ion channel activity
by: Zitzmann, N, et al.
Published: (2004)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
by: Woodhouse, S, et al.
Published: (2010)